Dr Shefali Khanna Sharma Publications

  • Kopp CR, Sharma SK, Krishnaraju VS, Sood A et al. Chemokine Receptor CXCR4 Based Positron Emission Tomography Imaging in Systemic Sclerosis- Related Interstitial Lung Disease. Rheumatology Oxford, DOI :10.1093/rheumatology/keae503.
  • Giles I, Thorne I, Schmidt NS, Reid C, Crossley A, Panca M, Freemantle N, Tower C, Dass S, Sharma SK, Williams D, O’Neill S, Dolhain RJEM, Toplak N, Hodson K, Nelson-Piercy C, Clowse MEB. The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: A reappraisal of evidence to optimize pregnancy management. Lancet Rheumatol. 2024;6(8): e546-e559.
  • Khullar A, Dhir V, Saikia B, Yadav AK, Sharma SK, et al. Rheumatoid arthritis synovial fluid shows enrichment of T-cells producing GMCSF which are polyfunctional for TNFα and IFNγ. Clin Exp Rheumatol. 2024;42(7):1435-1441.
  • Hampannavar M, Naidu GSRSNK, Sharma V, Sinha A, Dhir V, Sharma SK, Sharma A, Jain S. Prevalence and patterns of inflammatory arthritis and fibromyalgia in inflammatory bowel disease: A single-center, cross-sectional study. Indian J Gastroenterol. 2024;43(1):271-273.
  • Machhua S, Sharma SK, Minz RW, Pandey SK, Jindal A, Rawat A, Jindal AK. Heterozygous RAD50 gene variant in a family with systemic sclerosis suggests role of impaired DNA repair mechanisms in disease pathogenesis. Clin Exp Dermatol. 2024;49(5):543-546.
  • Jayaprakash S, Dhir V, Leishangthem B, Sharma SK, et al. AB0870 Efficacy of oral steroids for peripheral arthritis in spondyloarthritis: A double blind, parallel group, randomised control trial. Ann Rheum Dis. 2024;83(Suppl 1):1736.2-1736.
  • Khullar A, Dhir V, Saikia B, Yadav AK, Leishangthem B, Prasad CB, Jayaprakash S, Jain S, Naidu GSRSNK, Sharma SK, Sharma A, Jain S. Rheumatoid arthritis synovial fluid shows enrichment of T-cells producing GMCSF which are polyfunctional for TNFα and IFNγ. Clin Exp Rheumatol. 2024;42(7):1435- 1441.
  • Machhua S, Sharma SK, Minz RW, Rawat A, Jindal AK, Singh S. Familial aggregation of diffuse cutaneous systemic sclerosis: Interplay of C1r gene defect, susceptible HLA haplotype and autoantibodies. Int J Rheum Dis. 2024;27(6): Pe15247.
  • Khullar A, Dhir V, Saikia B, Yadav AK, Leishangthem B, Prasad CB, Jayaprakash S, Jain S, Naidu GSRSNK, Sharma SK, Sharma A, Jain S. Rheumatoid arthritis synovial fluid shows enrichment of T-cells producing GMCSF which are polyfunctional for TNFα and IFNγ. Clin Exp Rheumatol. 2024;42(7):1435- 1441.
  • Choudhary S, Chattopadhyay A, Gupta P, Mehta A, Jain S, Machhua S, Minz RW, Bansal R, Sehgal S, Pandav SS, Sharma SK. Ophthalmologic profile of patients with systemic sclerosis. J Clin Rheumatol. 2024 Aug 1;72(8):1192-1198.
  • Machhua S, Sharma SK, Minz RW, Pandey SK, Jindal A, et al. Heterozygous RAD50 gene variant in a family with systemic sclerosis suggests role of impaired DNA repair mechanisms in disease pathogenesis. Clin Exp Dermatol. 2023;49(5):543-546.
  • Machhua S, Sharma SK, Kumar Y, Singh S, Aggarwal R, Anand S, Kumar M, Singh H, Minz RW. Human leukocyte antigen association in systemic sclerosis patients: Our experience at a tertiary care center in North India. Front Immunol. 2023; 14:1179514.
  • Saikia UN, Dhanasekaran V, Sharma S, Chaluvashetty SB. A rare case of massive gastrointestinal bleeding as a cause of death in a young adult with catastrophic granulomatosis polyangiitis. J Postgrad Med Educ Res. 2023;57(3):147-152.
  • Bhargava M, Kopp CR, Naidu S, Dhibar DP, Kumar, Sharma SK, Jain S, Dhir V. Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity–a randomized controlled trial. Arthritis Res Ther. 2023;25(1):82.
  • Jain S, Dhir V, Aggarwal A, Gupta R, Maurya S, Leishangthem B, Khullar A, Sharma SK, et al. P122 Changes in serum levels of cytokines with methotrexate monotherapy in active rheumatoid arthritis: Results from a multicentre, randomized controlled trial on methotrexate escalation in rheumatoid arthritis. Rheumatology. 2023;62(Suppl 2): kead104-163.
  • Dhir V, Prasad CB, Kumar S, Sharma SK, et al. Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: A retrospective cohort study. Rheumatol Int. 2023;43(5):867-873.
  • Mathew J, Jain S, Susngi T, Naidu S, Dhir V, Sharma A, Jain S, Sharma SK. Predictors of Covid-19 severity and outcomes in Indian patients with rheumatic disease: A prospective cohort study. Rheumatol Adv Pract. 2023;7(1): rkad025.
  • Bhargava M, Kopp CR, Naidu S, Sharma SK. Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial. Arthritis Res Ther. 2023;25(1):82.
  • Sharma SK, Chaluvashetty SB, Dhanasekaran V, Saikia UN. A rare case of massive gastrointestinal bleeding as a cause of death in a young adult with catastrophic granulomatosis polyangiitis. J Postgrad Med. 2023;57(3):147-152.
  • Prasad CB, Dhir V, Naidu G, Sharma SK. Validation of revised 2022 ACR/EULAR remission criteria for rheumatoid arthritis in Asian Indian rheumatoid arthritis patients. Ann Rheum Dis. 2023;82(Suppl 1):1288- 1289.
  • Machhua S, Sharma SK, Kumar Y, Singh S, Aggarwal R, Anand S, Kumar M, Singh H, Minz RW. Human leukocyte antigen association in systemic sclerosis patients: Our experience at a tertiary care center in North India. Front Immunol. 2023; 10:1179514.
  • Vadher AB, Sinha A, Roy Choudhury S, Prakash M, Maralakunte M, Rehman T, Sharma S, Kumar Y. Ultrasound and magnetic resonance imaging of hands in systemic sclerosis: A cross-sectional analytical study of prevalence of inflammatory changes in patients with subclinical arthropathy. J Scleroderma Relat Disord. 2023;8(1):72-8.
  • Machhua S, Sharma SK, Kumar Y, et al. Detection of Epstein-Barr virus in systemic sclerosis patients: A molecular and serological based study. Int J Rheum Dis. 2022;25(12):1431-1436.
  • Jain S, Sharma SK, Suri V, et al. Hydroxychloroquine in treatment of asymptomatic and mildly symptomatic COVID-19: A multi-centre cohort study. J Assoc Physicians India. 2022;70(1):11-12.
  • Machhua S, Sharma SK, Kumar Y, et al. Antinuclear antibody pattern and autoantibody profiling of systemic sclerosis patients in a tertiary referral centre in North India. Pathol Int. 2022;72(5):283-292.
  • Relangi HSK, Naidu GSRSNK, Sharma V, Kumar M, Dhir V, Sharma SK, Sharma A, Minz R, Jain S. Association of immunological features with clinical manifestations in primary Sjogren’s syndrome: a single-centre cross-sectional study. Clin Exp Med. 2022;22(4):613-620.
  • Singh H, Kopp C, Sharma A, et al., Sharma S. Primary tuberculous myositis—Report of a case and systematic review of literature in the last 25 years. J Clin Rheumatol. 2022;28(1): e278-e281.
  • Jain S, Dhir V, Aggarwal A, Sharma SK, et al. Comparison of two dose escalation strategies of methotrexate in active rheumatoid arthritis: a multicentre, parallel group, randomized controlled trial. Ann Rheum Dis. 2021;80(11):1376-1384.
  • Jain S, Dhir V. Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the Care RA trial’. Ann Rheum Dis. 2021;82(7): e162.
  • Vijaykumar D, Dhir V, Jain S, Pai V, Kaur J, Naidu GS, Sharma A, Sharma SK. Assessing methotrexate intolerance and its prevalence in rheumatoid arthritis: Development and validation of the MISA questionnaire. Int J Rheum Dis. 2021;(10):1294-1301.
  • Sharma SK, Chattopadhyay A, Jain S, et al. Prognostic role of measurement of renal resistive index in systemic sclerosis. Mediterr J Rheumatol. 2021;32(4):345-349.
  • Kishor K, Mishra D, Jain S, Sharma SK. Prevalence of tuberculin skin test positivity in patients of early rheumatoid arthritis: Study from a tertiary care centre in North India. Int J Med Res Rev. 2021.
  • Sharma SK, Chattopadhyay A, Jain S, Sharma CJ, Mishra D, Rathi M, Prakash M, Jain S. Prognostic role of measurement of renal resistive index in systemic sclerosis. Mediterr J Rheumatol. 2021;32(4):345-349.
  • Dwivedi P, Adarsh MB, Acharya N, Ramachandran R, Nada R, Naidu S, Sharma SK, Sharma A, Jain S, Dhir V. Scleroderma renal crisis is associated with high mortality: A real-world study from India. J Assoc Physicians India. 2021;69(10):11-12.
  • Bagga R, Singh R, Bansal Y, Singh T, Mukhopadhyay K, et al., Sharma SK, et al. Legal abortion limit raised up to 24 weeks of gestation for substantial foetal anomalies or for rape victims: A welcome step for women and health providers in India. Asian Bioeth Rev. 2021;14(1):5-8.
  • Mishra D, Chattopadhyay A, Kavanal AJ, Kumar R, Sharma SK. Complex regional pain syndrome. Mediterr J Rheumatol. 2021;32(2):174-175.
  • Mittal S, Sharma SK. Lenabasum for systemic sclerosis—Are cannabinoids the missing link? Comment on the article by Spiera et al. Arthritis Rheumatol. 2021;73(4):715-716.
  • Kuma RR, Jha S, Dhooria A, Naidu GSRSNK, Minz RW, Kumar S, Sharma SK, Sharma A, Jain S, Dhir V. Anti–Jo-1 syndrome often misdiagnosed as rheumatoid arthritis (for many years): A single-center experience. J Clin Rheumatol. 2021;73(4):715-716.
  • Jain S, Jain S, Sharma SK. Tocilizumab in COVID-19: finding the optimal route and dose. Lancet Rheumatol. 2020;2(12): e738-e739.
  • Sharma SK, Jain S, Bahl P, et al. Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study. Arthritis Res Ther. 2020;22(1):189.
  • Jain S, Sharma SK. Rational use of tocilizumab in COVID-19. Ann Rheum Dis. 2020;81(11): e215.
  • Jain S, Sharma SK. Differentiating disease activity from damage in systemic sclerosis: it’s still early days! Ann Rheum Dis. 2020;79(8): e98.
  • Acharya N, Sharma SK, Mishra D, Dhooria S, Dhir V, Jain S. Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease: A randomized controlled trial. Rheumatol Int. 2020;40(5):703- 710.
  • Naidu GSRSNK, Sharma SK, Adarsh MB, Dhir V, Sinha A, Dhooria S, Jain S. Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: A double-blind, placebo-controlled, randomized trial. Rheumatol Int. 2020;40(2):207-216.
  • Mishra D, Dhir V, Naidu GSRSNK, Khullar A, Kumar V, Sharma SK, Sharma A, Jain S. Efficacy of a step-down regimen of oral prednisolone in axial spondylarthritis: Result of a double-blind randomized controlled trial (COBRA-AS Study). Rheumatology. 2020;60(4):1932-1941.
  • Mishra D, Sharma SK. Rare cause of red eye in scleroderma. BMJ Case Rep. 2020;13: e236042.
  • Chattopadhyay A, Samanta J, Sharma SK, Jain S. Classical hand radiology of gout, osteoarthritis and diffuse idiopathic skeletal hyperostosis (DISH). QJM. 2020;114(5):336-337.
  • Dhooria A, Gawalkar A, Santosh K, Bahl A, Adarsh MB, Naidu GSRSNK, Sharma S, Sharma A, Jain S, Dhir V. Acute myocardial dysfunction in lupus: Outcomes in Asian Indians. Clin Rheumatol. 2020;39(12):3661-3667.
  • Gawalkar A, Bahl A, Ahluwalia J, Sood A, Sharma A, Sharma S, Dhir V. Prevalence of antiphospholipid antibodies in patients with overt myocardial dysfunction in systemic lupus erythematosus: A case-control study. Lupus. 2020;1503-1508.
  • Dhooria A, Gawalkar A, Santosh K, Bahl A, Adarsh MB, Naidu GSRSNK, Sharma SK, Sharma A, Jain S, Dhir V. Acute myocardial dysfunction in lupus: Outcomes in Asian Indians. Clin Rheumatol. 2020;39(12):3661-3667.
  • Sharma SK, Chattopadhyay A, Dhir V, Kumar A. Nodal eosinophilic granulomatosis with polyangiitis (EGPA). J Clin Rheumatol. 2020;26(7): e259-e260.
  • Chattopadhyay A, Mishra D, Sharma SK. Calcinosis cutis at an unusual location. J Clin Rheumatol. 2020; e200.
  • Adarsh MB, Sharma SK, Dwivedi P. Methotrexate in early Chikungunya arthritis: A 6-month randomized controlled open-label trial. Curr Rheumatol Rev. 2020;16(4):319-323.
  • Sharma SK, Dhooria A, Singh T, Chattopadhyay A, Misra D. Response to comments on “Bone mineral density is decreased in patients with systemic sclerosis and correlates with serum intact parathormone levels: A cross-sectional study”. Indian J Rheumatol. 2019.
  • Dhooria A, Gawalkar A, Santosh K, Bahl A, Adarsh MB, Naidu GSRSNK, Sharma SK, Sharma A, Jain S, Dhir V. Acute myocardial dysfunction in lupus: Outcomes in Asian Indians. Clin Rheumatol. 2020;39(12):3661-3667.
  • Dwivedi P, Kumar RR, Dhooria A, Adarsh MB, Malhotra S, Kakkar N, Sharma SK, et al. Corticosteroid- associated lupus pancreatitis: A case series and systematic review of the literature. Lupus. 2019;28(6):731- 739.
  • Chattopadhyay A, Sharma SK, Sharma A, Jain S, Dhir V. Where does denosumab stand in the treatment of glucocorticoid-induced osteoporosis? Comment on the article by Saag et al. Arthritis Rheumatol. 2019;71(10):1770.
  • Chattopadhyay A, Sharma SK, Naidu S, Dhir V. Failure of etanercept and methotrexate combination therapy to surpass etanercept monotherapy in psoriatic arthritis—What about the joint counts? Comment on the article by Mease et al. Arthritis Rheumatol. 2019;71(11):1965-1966.
  • Chattopadhyay A, Sharma SK, Mishra D, Madakshira MG, De D, Jain S. Keloidal morphea. Clin Rheumatol. 2019;26(6): e178-e179.
  • Jain S, Sharma SK. Differentiating disease activity from damage in systemic sclerosis: It’s still early days! Ann Rheum Dis. 2019;79(8): e98.
  • Chattopadhyay A, Dhir V, Sharma SK, Sharma A, Jain S. Will SPAR be useful in the usual patients with scleroderma? Ann Rheum Dis. 2019;78(11): e125.
  • Adarsh MB, Bhattacharya A, Sharma SK, Dhir V, Sinha SK. Assessment of gastric emptying half time as a quantitative measure of gastrointestinal dysmotility in systemic sclerosis. Rheumatology. 2019;58(11):2064-2065.
  • Chattopadhyay A, Dhir V, Sharma S, Sharma A, Jain S. Will SPAR be useful in the usual patients with scleroderma? Ann Rheum Dis. 2019;78(11): e125.
  • Adarsh MB, Sharma SK, Prasad KK, Dhir V, Singh S, Sinha SK. Oesophageal manometry, esophagogastroduodenoscopy, and duodenal mucosal histopathology in systemic sclerosis. JGH Open. 2019;3(3):206-209.
  • Sinha A, Dhungana S, De D, Prakash M, Sharma S, Das A. Multi-centric reticulo histiocytosis: Clinical radiological review. Indian J Rheumatol. 2018;56(9):456.
  • Sharma SK, Singh T, Dhir V, Chattopadhyay A, Mishra D, Jain S. Bone mineral density is decreased in patients with systemic sclerosis and correlates with serum intact parathormone levels: A cross-sectional study. Indian J Rheumatol. 2018.
  • Sharma SK, Jain S. Chikungunya: A rheumatologist’s perspective. Int J Rheum Dis. 2018;21(3):584-601.
  • Sharma SK, Balasubramanian P, Radotra B, Singhal M. Isolated splenic mucormycosis in a case of aplastic anemia. BMJ Case Rep. 2018 Feb 8;2018: bcr2017223243.
  • Sharma SK, Adarsh MB, Trivedi P, Reddy M, Singh MP, Dhir V, et al. Characteristics and treatment of chronic Chikungunya virus: Comment on the article by Chang et al. Arthritis Rheumatol. 2018;70(11):1890-1891.
  • Mishra D, Sharma S, Sharma A, Jain S, Dhir V. Alopecia as the first manifestation of azathioprine myelosuppression in a genetically predisposed patient. Indian J Rheumatol. 2018;14(1):61-64.
  • Sharma SK, Kadiyala V, Naidu G, Dhir V. A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis. Int J Rheum Dis. 2018;21(1):308-314.
  • Gunashekar S, Prakash M, Minz RW, Sharma A, Sharma S, Dhir V. Comparison of articular manifestations of mixed connective tissue disease and systemic lupus erythematosus on clinical examination and musculoskeletal ultrasound. Lupus. 2018;27(13):2086-2092.
  • Dhooria A, Pandurangan N, Mahesh K, Sachdev S, Sharma A, Sharma S. Circulating levels of osteoprotegerin and sRANKL and the effect of methotrexate in patients with rheumatoid arthritis. Indian J Rheumatol. 2018.
  • Adarsh MB, Sharma SK, Sinha SK, Bhattacharya A, Rana S, Dhir V. Gastrointestinal dysmotility and infections in systemic sclerosis: An Indian scenario. Curr Rheumatol Rev. 2018;14(2):172-176.
  • Sharma SK. Use of biologics and biosimilars in rheumatology. J Assoc Physicians India. 2017;65(5 Suppl):9-14.
  • Sharma S, Mohanan S, Sharma SK. Effect of anti-tumor necrosis factor alpha therapy on bone health and biomarkers of bone turnover in Indian patients with ankylosing spondylitis. Indian J Rheumatol. 2017;12(1):31-37.
  • Sharma S, Dhooria A. Quantitating skin thickness in systemic sclerosis: The way ahead. Indian J Rheumatol. 2017;12(4):192-193.
  • Santosh K, Dhir V, Singh S, Sood A, Gupta A, Sharma A, Sharma S. Prevalence of secondary Sjogren’s syndrome in Indian patients with rheumatoid arthritis: A single-center study. Int J Rheum Dis. 2017;20(7):870-874.
  • Sandhu A, Dhir V, Bhatnagar A, Dhawan V, Kaur J, et al., Sharma S. High methotrexate triglutamate level is an independent predictor of adverse effects in Asian Indian rheumatoid arthritis patients: A preliminary study. Ther Drug Monit. 2017;39(2):157-163.
  • Kumar A, Dhir V, Sharma S, Sharma A, Singh S. Efficacy of methylprednisolone acetate versus triamcinolone acetonide intra-articular knee injection in patients with chronic inflammatory arthritis: A 24- week randomized controlled trial. Clin Ther. 2017;39(1):150-158.
  • 2016

  • Singh PK, Sharma SK, Sinha A, Dutta P. Can thyroid volume predict thyroid dysfunction in patients with
    systemic sclerosis? A prospective cross-sectional study from a tertiary care center in Northwest India. Clin
    Rheumatol. 2016;35(3):765-9.
  • Sharma SK, Rathi M, Sahoo S, Prakash M, Dhir V, Singh S. Assessment of premature atherosclerosis in
    systemic lupus erythematosus patients with and without nephritis. Lupus. 2016;525-31.
    Sharma SK, Naidu G. The role of danger-associated molecular patterns (DAMPs) in trauma and infections.
    J Thorac Dis. 2016;8(7):1406-9.
  • Sharma A, Pinto B, Dogra S, Sharma K, Goyal P, Sagar V. A case series and review of Poncet’s disease,
    and the utility of current diagnostic criteria. Int J Rheum Dis. 2016;19(10):1010-1017.
  • Dhir V, Sandhu A, Bhatnagar A, Dhawan V, Kaur J, Sood A, Sharma SK, et al. FRI0103 Erythrocyte
    methotrexate polyglutamate levels do not determine efficacy and tolerability of methotrexate in rheumatoid
    arthritis. Ann Rheum Dis. 2016; 75:461-465.
  • 2015

  • Sharma SK, Prasad KT, Handa R, Sharma SK. Increased prevalence of subclinical atherosclerosis in
    ankylosing spondylitis. Indian J Rheumatol. 2015;35(3):335-342.
  • Dhir V, Sandhu A, Kaur J, Pinto B, Kumar P, Sharma S. Comparison of two different folic acid doses with
    methotrexate—a randomized controlled trial (FOLVARI Study). Arthritis Res Ther. 2015;17(1):156.
  • 2014

  • Sharma S, Panda A, Jana M, Arora A, Sharma SK. Ophthalmic manifestations of systemic diseases—part
    1: Phacomatoses, hematologic malignancies, metastases, and histiocytosis. Curr Probl Diagn Radiol.
    2014;43(4):175-85.
  • Dhir V, Singla M, Gupta N, Goyal P, Sagar V, Sharma A, Sharma SK, Singh S. Randomized controlled
    trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis. Clin Ther.
    2014;36(7):1005-15.
  • Dhir V, Sandhu A, Gupta N, Sharma A, Sharma S. Change in CXCL10 on treatment with methotrexate
    similar to that reported with infliximab: Comments on the article by Eriksson et al. Scand J Rheumatol.
    2014;43(1):83-4.
  • 2013

  • Sharma SK, Hadda V, Mathur P, Gulati V, Sahney C. Profile of micro-organisms in intensive care unit of
    a level 1 trauma centre: A retrospective study. Indian J Crit Care Med. 2013;17(2):87-91.
  • Sharma A, Dogra S, Pinto B, Sharma K, Singh R, Dhir V, Sharma SK. Poncet’s disease presenting as
    pseudo-Behcet’s disease. Int J Rheum Dis. 2013;16(4):483-5.
  • Dhir V, Sandhu A, Gupta N, Dhawan V, Sharma S. Low serum levels of myeloid progenitor inhibitory
    factor-1 predict good response to methotrexate in rheumatoid arthritis. ISRN Inflamm. 2013; 2013:460469.
  • 2012

  • Singla M, Arivarasan K, Dhir V, Sharma P, Sharma A, Sharma S, Singh S. Medical image: An unusual
    cause of massive splenomegaly in an adult. Gaucher’s disease. N Z Med J. 2012;125(1361):98-101.
    Singla M, Arivarasan K, Dhir V, Sharma P, Sharma A, Sharma S. An unusual cause of massive
    splenomegaly in an adult. Gaucher’s disease. N Z Med J. 2012;125(1361):98-101.
  • 2009

  • Wanchu A, Suryanarayana BS, Sharma S, Sharma A, Bambery P. High-dose prednisolone and bolus
    cyclophosphamide in interstitial lung disease associated with systemic sclerosis: A prospective open study.
    Int J Rheum Dis. 2009;12(3):239-42.
  • Agarwal, A., Aggarwal, R., Agarwal, A., Agarwal, S., Ahluwalia, G., Barwad, P., & Verma, N & Sharma
    S et al (2009). The Association of Physicians of India evidence-based clinical practice guidelines on adult
    immunization. Journal of the Association of Physicians of India, 2009 Apr:57:345-56.
  • 2007

  • Sharma SK, Sharma A, Bambery P. To develop and validate a health-related quality of life scale for
    rheumatoid arthritis patients in a North Indian setting. Intern Med J. 2007;37(2 Suppl): A52.
  • 2006

  • Sharma A, Sharma SK, Wanchu A, Kumar M, Singh S, Bambery P. Lower-back pain, intervertebral-disc
    calcification and scleral pigmentation. Med J Aust. 2006;184(12):643.
  • 2005

  • Sharma SK, Malhotra P, Kumar M, Sharma A, Varma N, Singh S. Spontaneous tumor lysis syndrome in
    acute lymphoblastic leukemia. J Assoc Physicians India. 2005; 53:828-30.
  • 2004

  • Sharma SK, Handa R, Sood R, Aggarwal P, Biswas A, Kumar U, et al. Bleomycin-induced scleroderma. J
    Assoc Physicians India. 2004; 52:76-7.
  • Sharma S, Guglani B, Gamagati S, Sharma S, Vijayraghavan M, Nayak A, et al. Metastatic nodal
    calcification in aggressive chromophobe renal cell carcinoma. Clin Radiol Extra. 2004; 59:128-32.
  • Ghai S, Gupta R, Ghai S, Sharma SK, Dey AB. Unusual serosal calcifications in CREST syndrome. Clin
    Radiol Extra. 2004; 59:91-3.
  • 2003

  • Sharma SK, Khilani GC, Banga A. Amyloidosis—An experience with ten patients. J Assoc Physicians
    India. 2003; 51:1269.
  • Sharma SK, Khilani GC, Banga A. Amyloidosis—An experience with ten patients. J Assoc Physicians
    India. 2003; 51:1269.
  • Banga A, Khilani GC, Sharma SK. Serum albumin as a prognostic marker in critically ill patients. J Assoc
    Physicians India. 2003; 51:1223-4.

Papers Under Publications

Mittal S, Sharma AK, Dhir V, Sharma V, Dhooria A, Mishra D, Jain S, Sharma SK. Evaluation of faecal
calprotectin as a biomarker for spondylarthritis. Semin Arthritis Rheum. 2023.

Publication In Non Indexed Journals

Sharma SK, Balasubramanian P, Dhir V, Sharma A, Jain S. Gastrointestinal amyloidosis manifesting as
chronic diarrhea in a case of rheumatoid arthritis. Biomed J Sci Tech Res. 2018.